.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Chubb
Argus Health
Federal Trade Commission
Medtronic
Boehringer Ingelheim
US Army
Covington
US Department of Justice
Colorcon

Generated: September 19, 2017

DrugPatentWatch Database Preview

DONEPEZIL HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Donepezil Hydrochloride, and when can generic versions of Donepezil Hydrochloride launch?

Donepezil Hydrochloride is a drug marketed by Zydus Pharms Usa Inc, Dr Reddys Labs Ltd, Twi Pharms Inc, Sciegen Pharms Inc, Zhejiang Hisun Pharm, Dexcel Pharma, Cspc Ouyi Pharm Co, Osmotica Pharm Us, Actavis Elizabeth, Cipla Ltd, Indicus Pharma, Mylan Pharms Inc, Alembic Pharms Ltd, Pliva Hrvatska Doo, Unichem Labs Ltd, Macleods Pharms Ltd, Hetero Labs Ltd V, Accord Hlthcare, Apotex, Par Pharm, Teva, Hikma Pharms, Vivimed Global, Aurobindo, Aci Healthcare Ltd, Wockhardt, Jubilant Generics, Sun Pharm Inds, Lupin Ltd, Sun Pharm Inds Ltd, Torrent Pharms, Barr, Sandoz, and Prinston Inc. and is included in forty-five NDAs.

The generic ingredient in DONEPEZIL HYDROCHLORIDE is donepezil hydrochloride. There are thirty-one drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the donepezil hydrochloride profile page.

Summary for Tradename: DONEPEZIL HYDROCHLORIDE

Patents:0
Applicants:34
NDAs:45
Suppliers / Packagers: see list55
Bulk Api Vendors: see list86
Clinical Trials: see list2,492
Patent Applications: see list2,866
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DONEPEZIL HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: DONEPEZIL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Prinston Inc
DONEPEZIL HYDROCHLORIDE
donepezil hydrochloride
TABLET;ORAL200292-002May 31, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Hikma Pharms
DONEPEZIL HYDROCHLORIDE
donepezil hydrochloride
TABLET;ORAL090247-002May 31, 2011DISCNNoNo► Subscribe► Subscribe► Subscribe
Accord Hlthcare
DONEPEZIL HYDROCHLORIDE
donepezil hydrochloride
TABLET;ORAL201335-002Aug 29, 2011DISCNNoNo► Subscribe► Subscribe► Subscribe
Aci Healthcare Ltd
DONEPEZIL HYDROCHLORIDE
donepezil hydrochloride
TABLET;ORAL078662-001May 31, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Ltd
DONEPEZIL HYDROCHLORIDE
donepezil hydrochloride
TABLET;ORAL202782-001Oct 30, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo
DONEPEZIL HYDROCHLORIDE
donepezil hydrochloride
TABLET;ORAL090056-002May 31, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Aci Healthcare Ltd
DONEPEZIL HYDROCHLORIDE
donepezil hydrochloride
TABLET;ORAL078662-002May 31, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Jubilant Generics
DONEPEZIL HYDROCHLORIDE
donepezil hydrochloride
TABLET;ORAL090768-002May 31, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
DONEPEZIL HYDROCHLORIDE
donepezil hydrochloride
TABLET;ORAL076786-001Nov 26, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
DONEPEZIL HYDROCHLORIDE
donepezil hydrochloride
TABLET;ORAL203034-002Jan 30, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Medtronic
Chubb
US Department of Justice
Mallinckrodt
McKesson
Accenture
Federal Trade Commission
Chinese Patent Office
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot